Edgewise Therapeutics, Inc. (EWTX)
24.12
-0.78
(-3.11%)
USD |
NASDAQ |
Jan 12, 16:00
24.12
0.00 (0.00%)
After-Hours: 20:00
Edgewise Therapeutics Research and Development Expense (Quarterly): 36.96M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Dynavax Technologies Corp. | 19.12M |
| Omeros Corp. | 15.76M |
| Gilead Sciences, Inc. | 1.334B |
| Agios Pharmaceuticals, Inc. | 85.42M |
| NovaBay Pharmaceuticals, Inc. | -- |